Last year I wrote on Suven Life Sciences, also I did some secondary level maths to get a sense of returns an investor could get buying the business at then market cap (~2000 INR Crores or 400 Million USD) and exiting in 2024
See Snap shot below
The base case CAGR didn’t excite but reading management commentary compelled me to take a tracking position in model portfolio
Over to this year
One thing in AR gave me a Jeff Bezos moment
For the first time management was sounding optimistic (this is coming from a management which is very conservative on record)
Emphasis mine
Management views on past
Despite having grown the business every single year across the last five years, our business sustainability has been consistently questioned. We are perceived as a high risk service-based business marked by volatile quarter on quarter earnings because successful project completion may not necessarily translate into repeat orders if the project does not carry through at the innovator’s end
Management views on Future
… Read the restThe big message that I wish to send out is that this reality is likely to change. The volatility in our business model may moderate extensively following the commercialisation of